The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany [0.03%]
经导管主动脉瓣植入术后并发症对德国患者报销、住院时长和机械通气影响的分析
Klaus Kaier,Holger Reinecke,Huseyin Naci et al.
Klaus Kaier et al.
Background: The impact of various post-procedural complications after transcatheter aortic valve implantation (TAVI) on resource use and their consequences in the German reimbursement system has still not been properly qu...
A methodological proposal to evaluate the cost of duration moral hazard in workplace accident insurance [0.03%]
评估工伤保险中延迟申报逆向选择成本的方法论提案
Ángel Martín-Román,Alfonso Moral
Ángel Martín-Román
The cost of duration moral hazard in workplace accident insurance has been amply explored by North-American scholars. Given the current context of financial constraints in public accounts, and particularly in the Social Security system, we ...
Qiang Li,Lian An,Jing Xu et al.
Qiang Li et al.
This paper investigates the effect of corruption on health outcomes by using cross-country panel data covering about 150 countries for the period of 1995 to 2012. We employ ordinary least squares (OLS), fixed-effects and two-stage least squ...
Katharina Elisabeth Fischer,Taika Koch,Karel Kostev et al.
Katharina Elisabeth Fischer et al.
To contain pharmaceutical spending, drug budgets have been introduced across health systems. Apart from analyzing whether drug budgets fulfill their overall goal of reducing spending, changes in the cost and quality of prescribing and the e...
The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach [0.03%]
糖尿病给法国国家健康保险造成的经济负担：一种新的疾病负担计算方法及其医疗和增量途径的结合应用
Grégoire de Lagasnerie,Anne-Sophie Aguadé,Pierre Denis et al.
Grégoire de Lagasnerie et al.
A better understanding of the economic burden of diabetes constitutes a major public health challenge in order to design new ways to curb diabetes health care expenditure. The aim of this study was to develop a new cost-of-illness method in...
Frank Eijkenaar,René C J A van Vliet
Frank Eijkenaar
Background: Worldwide, risk-equalization (RE) models in competitive health insurance markets have evolved from simple demographic models to sophisticated models containing diagnosis and pharmacy-based indicators of health...
A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations [0.03%]
基于试验的经济评估中用于治疗成本和效果的替代数据的成本效益结果的一致性评估方法框架
Felix Achana,Stavros Petrou,Kamran Khan et al.
Felix Achana et al.
A new methodological framework for assessing agreement between cost-effectiveness endpoints generated using alternative sources of data on treatment costs and effects for trial-based economic evaluations is proposed. The framework can be us...
Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial [0.03%]
痴呆患者初级保健利用和费用：DelpHi试验基线结果
Bernhard Michalowsky,Steffen Flessa,Tilly Eichler et al.
Bernhard Michalowsky et al.
The objectives of this cross-sectional analysis were to determine healthcare resource utilization and cost for community-dwelling patients with dementia (PWD) from a payer's and societal perspective, and to analyze the associations between ...
A "healthy immigrant effect" or a "sick immigrant effect"? Selection and policies matter [0.03%]
“移民有利选择效应”还是“移民不利选择效应”?取舍和政策至关重要
Amelie F Constant,Teresa García-Muñoz,Shoshana Neuman et al.
Amelie F Constant et al.
Previous literature on a variety of countries has documented a "healthy immigrant effect" (HIE). Accordingly, immigrants arriving in the host country are, on average, healthier than comparable natives. However, their health status dissipate...
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK [0.03%]
英国成人注意缺陷多动障碍使用利斯德明治疗的成本效益分析
Evelina A Zimovetz,Alain Joseph,Rajeev Ayyagari et al.
Evelina A Zimovetz et al.
Background: Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobehavioral disorder in children that may persist into adulthood. Lisdexamfetamine dimesylate (LDX) is approved in many countries for ADHD treat...